{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T04:06:26Z","timestamp":1754193986311},"reference-count":42,"publisher":"Japan Atherosclerosis Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2022,2,1]]},"DOI":"10.5551\/jat.59394","type":"journal-article","created":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T22:06:35Z","timestamp":1610834795000},"page":"252-267","source":"Crossref","is-referenced-by-count":7,"title":["Changes in Body Weight and Concurrent Changes in Cardiovascular Risk Profiles in Community Residents in Japan: the Hisayama Study"],"prefix":"10.5551","volume":"29","author":[{"given":"Takanori","family":"Honda","sequence":"first","affiliation":[{"name":"Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Oda","sequence":"additional","affiliation":[{"name":"Clinical Science Division, R&D Janssen Pharmaceutical K K"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Clinical Science Division, R&D Janssen Pharmaceutical K K"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanmei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoko","family":"Sakata","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University"},{"name":"Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University"},{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"Oishi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University"},{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Furuta","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University"},{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"},{"name":"Department of Medical-Engineering Collaboration for Healthy Longevity, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daigo","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichiro","family":"Hirakawa","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University"},{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Hata","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University"},{"name":"Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University"},{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanari","family":"Kitazono","sequence":"additional","affiliation":[{"name":"Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University"},{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiharu","family":"Ninomiya","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University"},{"name":"Center for Cohort Studies, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, and Eckel RH: American Heart Association; Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism: Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation, 2006; 113: 898-918","DOI":"10.1161\/CIRCULATIONAHA.106.171016"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corr\u00e0 U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, L\u00f8chen ML, L\u00f6llgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WMM, and Binno S: ESC Scientific Document Group 2016 European guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J, 2016; 37: 2315-2381","DOI":"10.1093\/eurheartj\/ehw106"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Bray GA, Heisel WE, Afshin A, Jensen MD, Dietz WH, Long M, Kushner RF, Daniels SR, Wadden TA, Tsai AG, Hu FB, Jakicic JM, Ryan DH, Wolfe BM, and Inge TH: The science of obesity management: an EndocrineSociety scientific statement. Endocr Rev, 2018; 39: 79-132","DOI":"10.1210\/er.2017-00253"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Ma C, Avenell A, Bolland M, Hudson J, Stewart F, Robertson C, Sharma P, Fraser C, and MacLennan G: Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis. BMJ, 2017; 359: j4849","DOI":"10.1136\/bmj.j4849"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Patnode CD, Evans CV, Senger CA, Redmond N, and Lin JS: Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention inadults without known cardiovascular disease risk factors: updated evidence report and systematic review for the US preventive services task force. JAMA, 2017; 318: 175-193","DOI":"10.1001\/jama.2017.3303"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Navar AM, Wang TY, Mi X, Robinson JG, Virani SS, Roger VL, Wilson PWF, Goldberg AC, and Peterson ED: Influence of cardiovascular risk communication tools and presentation formats on patient perceptions and preferences. JAMA Cardiol, 2018; 3: 1192-1199","DOI":"10.1001\/jamacardio.2018.3680"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) N\u00e4slund U, Ng N, Lundgren A, Fh\u00e4rm E, Gr\u00f6nlund C, Johansson H, Lindahl B, Lindahl B6, Lindvall K, Nilsson SK, Nordin M, Nordin S, Nyman E, Rockl\u00f6v J, Vanoli D, Weinehall L, Wennberg P, Wester P, and Norberg M: VIPVIZA trial group: Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial. Lancet, 2019; 393: 133-142","DOI":"10.1016\/S0140-6736(18)32818-6"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Mu\u00f1oz D, Smith SC Jr, Virani SS, Williams KA Sr, Yeboah J, and Ziaeian B: 2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 2019; 140: e596-e646","DOI":"10.1161\/CIR.0000000000000678"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Norris SL, Zhang X, Avenell A, Gregg E, Schmid CH, and Lau J: Long-term non-pharmacological weight loss interventions for adults with prediabetes. Cochrane Database Syst Rev, 2005: CD005270","DOI":"10.1002\/14651858.CD005270"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Franz MJ, Boucher JL, Rutten-Ramos S, and VanWormer JJ: Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials. J Acad Nutr Diet, 2015; 115: 1447-1463","DOI":"10.1016\/j.jand.2015.02.031"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Heneghan C, Goldacre B, and Mahtani KR: Why clinical trial outcomes fail to translate into benefits for patients. Trials, 2017; 18: 1-7","DOI":"10.1186\/s13063-017-1870-2"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Dunbar JA, Hernan Al, Janus ED, Vartiainen E, Laatikainen T, Versace VL, Reynolds J, Best JD, Skinner TC, O\u2019Reilly SL, Mc Namara KP, Stewart E, Coates M, Bennet CM, and Carter R: Challenges of diabetes prevention in the real world: results and lessons from the Melbourne Diabetes Prevention Study. BMJ Open Diabetes Res Care, 2015; 3: e000131","DOI":"10.1136\/bmjdrc-2015-000131"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Pomeroy J and Palacios C: Translating findings from lifestyle intervention trials of cariovascualr disease and diabetes to the primary care setting. Curr Nutr Rep, 2012; 1: 215-221","DOI":"10.1007\/s13668-012-0024-0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Ninomiya T: Japanese legacy cohort studies: the Hisayama Study. J Epidemiol, 2018; 28: 444-451","DOI":"10.2188\/jea.JE20180150"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Friedewald W, Levy R, and Fredrickson D: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18: 499-502","DOI":"10.1093\/clinchem\/18.6.499"},{"key":"16","unstructured":"16) Japan Society for the Study of Obesity. Guidelines for the management of obesity disease. 2016. Life Science Publishing Co. 2016"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Honda T, Yoshida D, Hata J, Hirakawa Y, Ishida Y, Shibata M, Sakata S, Kitazono T, and Ninomiya T: Development and validation of modified risk prediction models for cardiovascular disease and its subtypes: the Hisayama Study. Atherosclerosis, 2018; 279: 38-44","DOI":"10.1016\/j.atherosclerosis.2018.10.014"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Tsushita K, Hosler AS, Miura K, Ito Y, Fukuda T, Kitamura A, and Tatara K: Rationale and descriptive analysis of specific health guidance: the nationwide lifestyle intervention program targeting metabolic syndrome in Japan. J Atheroscler Thromb, 2018; 25: 308-322","DOI":"10.5551\/jat.42010"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Horio M, Imai E, Yasuda Y, Watanabe T, and Matsuo S: Modification of the CKD Epidemiology Collaboration (CKD-EPI) Equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis, 2010; 56: 32-38","DOI":"10.1053\/j.ajkd.2010.02.344"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Hillier TA, Fagot-Campagna A, Eschw\u00e8ge E, Vol S, Cailleau M, and Balkau B: D.E.S.I.R. Study group: Weight change and changes in the metabolic syndrome as the French population moves towards overweight: the D.E.S.I.R. cohort. Int J Epidemiol, 2006; 35: 190-19618","DOI":"10.1093\/ije\/dyi281"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21) Lee JS, Kawakubo K, Kobayashi Y, Mori K, Kasihara H, and Tamura M: Effects of ten year body weight variability on cardiovascular risk factors in Japanese middle-aged men and women. Int J Obes, 2001; 25(7): 1063-1067. doi: 10.1038\/sj.ijo.0801633","DOI":"10.1038\/sj.ijo.0801633"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Truesdale KP, Stevens J, and Cai J: The effect of weight history on glucose and lipids: the Atherosclerosis Risk in Communities Study. Am J Epidemiol, 2005; 161: 1133-1143","DOI":"10.1093\/aje\/kwi151"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Truesdale KP, Stevens J, and Cai J: Differences in cardiovascular disease risk factors by weight history: the Aerobics Center Longitudinal Study. Obesity, 2009; 19: 2063-2068","DOI":"10.1038\/oby.2011.41"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Brown JD, Buscemi J, Milsom V, Malcolm R, and O\u2019Neil PM: Effects on cardiovascular risk factors of weight losses limited to 5\u201310%. Transl Behav Med, 2016; 6(3): 339-346","DOI":"10.1007\/s13142-015-0353-9"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Vetter ML, Wadden TA, Chittams J, Diewald LK, Panigrahi E, Volger S, Sarwer DB, and Moore RH: POWER-UP Research Group: Effect of lifestyle intervention on cardiometabolic risk factors: results of the POWER-UP trial. Int J Obes, 2013; 37: S19-S24","DOI":"10.1038\/ijo.2013.92"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Muramoto A, Matsushita M, Kato A, Yamamoto N, Koike G, Nakamura M, Numata T, Tamakoshi A, and Tsushita K: Three percent weight reduction is the minimum requirement to improve health hazards in obese and overweight people in Japan. Obes Res Clin Pract, 2014; 8: e466-e475","DOI":"10.1016\/j.orcp.2013.10.003"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Borel AL, Nazare JA, Baillot A, Alm\u00e9ras N, Tremblay A, Bergeron J, Poirier P, and Despr\u00e9s JP: Cardiometabolic risk improvement in response to a 3-yr lifestyle modification program in men: contribution of improved cardiorespiratory fitness vs. weight loss. Am J Physiol - Endocrinol Metab, 2017; 312: E273-E281","DOI":"10.1152\/ajpendo.00278.2016"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Aucott L, Poobalan A, Smith WCS, Avenell A, Jung R, and Broom J: Effects of weight loss in overweight\/obese individuals and long-term hypertension outcomes: a systematic review. Hypertension, 2005; 45: 1035-1041","DOI":"10.1161\/01.HYP.0000165680.59733.d4"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Aucott L, Rothnie H, McIntyre L, Thapa M, Waweru C, and Gray D: Long-term weight loss from lifestyle intervention benefits blood pressure?: a systematic review. Hypertension, 2009; 54: 756-762","DOI":"10.1161\/HYPERTENSIONAHA.109.135178"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Markus MRP, Ittermann T, Baumeister SE, Troitzsch P, Schipf S, Lorbeer R, Aumannn N, Wallaschofski H, D\u00f6rr M, Rettig R, and V\u00f6lzke H: Long-term changes in body weight are associated with changes in blood pressure levels. Nutr Metab Cardiovasc Dis, 2015; 25: 305-311","DOI":"10.1016\/j.numecd.2014.10.011"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Poobalan A, Aucott L, Smith WCS, Avenell A, Jung R, Broom J, and Grant AM: Effects of weight loss in overweight\/obese individuals and long-term lipid outcomes: a systematic review. Obes Rev, 2004; 5: 43-50","DOI":"10.1111\/j.1467-789X.2004.00127.x"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Dattilo AM and Kris-Etherton PM: Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr, 1992; 56: 320-328","DOI":"10.1093\/ajcn\/56.2.320"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Rodr\u00edguez-hern\u00e1ndez H, Cervantes-huerta M, Rodr\u00edguez-moran M, and Guerrero-romero F: Decrease of aminotransferase levels in obese women is related to body weight reduction, irrespective of type of diet. Ann Hepatol, 2019; 10: 486-492","DOI":"10.1016\/S1665-2681(19)31517-0"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Koutoukidis DA, Astbury NM, Tudor KE, Morris E, Henry JA, Noreik M, Jebb SA, and Aveyard P: Association of weight loss interventions with changes in biomarkers of nonalcoholic fatty liver disease: a systematic review and meta-analysis. JAMA Intern Med, 2019; 179: 1262-1271","DOI":"10.1001\/jamainternmed.2019.2248"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Marchesini G, Petta S, and Dalle Grave R: Diet, weight loss, and liver health in nonalcoholic fatty liver disease: pathophysiology, evidence, and practice. Hepatology, 2016; 63: 2032-2043","DOI":"10.1002\/hep.28392"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Ghouri N, Preiss D, and Sattar N: Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical rerspective of prospective data. Hepatology, 2010; 52: 1156-1161","DOI":"10.1002\/hep.23789"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Targher G and Byrne CD: Circulating markers of liver function and cardiovascular disease risk. Arter Thromb Vasc Biol, 2015; 35: 2290-2296","DOI":"10.1161\/ATVBAHA.115.305235"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Kim JH, Shin JH, Lee HJ, Kim SY, and Bae HY: Discordance between HbA1c and fasting plasma glucose criteria for diabetes screening is associated with obesity and old age in Korean individuals. Diabetes Res Clin Pract, 2011; 94: 10-12","DOI":"10.1016\/j.diabres.2011.07.013"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Amedican Diabetes Association. 8. Obesity management for the treatment of type 2 diabetes: standards of medical care in diabetes-2020. Diabetes Care, 2020; 43: S89-S97","DOI":"10.2337\/dc20-S008"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Diehl AM: Fatty liver, hypertension, and the metabolic syndrome. Gut, 2004; 53: 923-924","DOI":"10.1136\/gut.2003.037309"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Tamura U, Tanaka T, Okamura T, Kadowaki T, Yamato H, Tanaka H, Nakamura M, Okayama A, Ueshima H, and Yamagata Z, for the HIPOP-OHP Research Group: Changes in weight, cardiovascualr risk factors, and estimated risk of coronary heart disease following smoking cessation in Japanese male workers: HIPOP-OHP Study. J Atheroscler Thromb, 2010; 17: 12-20","DOI":"10.5551\/jat.1800"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Takayama S, Takase H, Tanaka T, Sugiura T, Ohte N, Dohi Y: Smoking cessation without educational instruction could promote the development of metabolic syndrome. J Atheroscler Thromb, 2018; 25: 90-97","DOI":"10.5551\/jat.40063"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/2\/29_59394\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:27:07Z","timestamp":1715232427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/2\/29_59394\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.59394","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]},"article-number":"59394"}}